BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15107263)

  • 1. Parathyroid hormone in osteoporosis.
    Purdie DW; Rees M
    J Br Menopause Soc; 2003 Dec; 9(4):175. PubMed ID: 15107263
    [No Abstract]   [Full Text] [Related]  

  • 2. Parathyroid hormone.
    Madore GR; Sherman PJ; Lane JM
    J Am Acad Orthop Surg; 2004; 12(2):67-71. PubMed ID: 15089079
    [No Abstract]   [Full Text] [Related]  

  • 3. Parathyroid hormone analogues in the therapy of osteoporosis.
    Müller M; Pietschmann P
    Wien Klin Wochenschr; 2008; 120(11-12):321-4. PubMed ID: 18709518
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic potential of parathyroid hormone.
    Cosman F; Lindsay R
    Curr Osteoporos Rep; 2004 Mar; 2(1):5-11. PubMed ID: 16036076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teriparatide and raloxifene reduce the risk of new adjacent vertebral fractures in postmenopausal women with osteoporosis. Results from two randomized controlled trials.
    Bouxsein ML; Chen P; Glass EV; Kallmes DF; Delmas PD; Mitlak BH
    J Bone Joint Surg Am; 2009 Jun; 91(6):1329-38. PubMed ID: 19487509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latest innovation in the treatment of osteoporosis: SERMs and the role of parathyroid hormone.
    Thiebaud D
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S124-5. PubMed ID: 21213508
    [No Abstract]   [Full Text] [Related]  

  • 7. Summaries for patients. Parathyroid hormone (1-84) and risk for spinal fractures in women with osteoporosis.
    Ann Intern Med; 2007 Mar; 146(5):I20. PubMed ID: 17339614
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.
    Greenspan SL; Bone HG; Ettinger MP; Hanley DA; Lindsay R; Zanchetta JR; Blosch CM; Mathisen AL; Morris SA; Marriott TB;
    Ann Intern Med; 2007 Mar; 146(5):326-39. PubMed ID: 17339618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.
    Neer RM; Arnaud CD; Zanchetta JR; Prince R; Gaich GA; Reginster JY; Hodsman AB; Eriksen EF; Ish-Shalom S; Genant HK; Wang O; Mitlak BH
    N Engl J Med; 2001 May; 344(19):1434-41. PubMed ID: 11346808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY
    Clin Evid; 2002 Jun; (7):979-82. PubMed ID: 12230720
    [No Abstract]   [Full Text] [Related]  

  • 11. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group.
    Chesnut CH; Silverman S; Andriano K; Genant H; Gimona A; Harris S; Kiel D; LeBoff M; Maricic M; Miller P; Moniz C; Peacock M; Richardson P; Watts N; Baylink D
    Am J Med; 2000 Sep; 109(4):267-76. PubMed ID: 10996576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture prevention in postmenopausal women.
    Bruyere O; Reginster JY; Edwards J
    Clin Evid; 2002 Dec; (8):1089-102. PubMed ID: 12603931
    [No Abstract]   [Full Text] [Related]  

  • 13. Menostar: a low-dose estrogen patch for osteoporosis.
    Obstet Gynecol; 2005 Feb; 105(2):432-3. PubMed ID: 15684177
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic management of osteoporosis.
    Aynardi M; Ilyas AM
    J Hand Surg Am; 2013 Mar; 38(3):588-92. PubMed ID: 23312206
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy of osteoporosis with bisphosphonate. Bone quality maintained over years].
    MMW Fortschr Med; 2003 Jun; 145(23):59. PubMed ID: 12854232
    [No Abstract]   [Full Text] [Related]  

  • 16. [Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
    MMW Fortschr Med; 2004 Mar; 146(10):46. PubMed ID: 15347088
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of osteoporosis with vitamin D.
    Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
    Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of 5-year treatment with elcatonin and alfacalcidol on lumbar bone mineral density and the incidence of vertebral fractures in postmenopausal women with osteoporosis: a retrospective study.
    Iwamoto J; Takeda T; Ichimura S; Uzawa M
    J Orthop Sci; 2002; 7(6):637-43. PubMed ID: 12486466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Denosumab treatment in postmenopausal women with osteoporosis does not interfere with fracture-healing: results from the FREEDOM trial.
    Adami S; Libanati C; Boonen S; Cummings SR; Ho PR; Wang A; Siris E; Lane J; ; Adachi JD; Bhandari M; de Gregorio L; Gilchrist N; Lyritis G; Möller G; Palacios S; Pavelka K; Heinrich R; Roux C; Uebelhart D
    J Bone Joint Surg Am; 2012 Dec; 94(23):2113-9. PubMed ID: 23097066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of osteoporosis with parathyroid hormone].
    Syversen U; Halse JI
    Tidsskr Nor Laegeforen; 2008 Jan; 128(1):39-41. PubMed ID: 18183056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.